Haemoadsorption in infective endocarditis: a systematic review.
Cardiac surgery
CytoSorb®
Haemoadsorption
Infective endocarditis
Journal
Indian journal of thoracic and cardiovascular surgery
ISSN: 0970-9134
Titre abrégé: Indian J Thorac Cardiovasc Surg
Pays: India
ID NLM: 8700105
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
27
12
2023
revised:
24
01
2024
accepted:
24
01
2024
medline:
3
6
2024
pubmed:
3
6
2024
entrez:
3
6
2024
Statut:
ppublish
Résumé
Infective endocarditis surgical patients suffer from high rates of severe complications such as systemic inflammatory response, septic shock, and multi-organ failure leading to high mortality. Systemic inflammatory response based on cytokines as messengers plays an important role in these patients. The concept of intraoperative haemoadsorption has been proposed to remove such elevated cytokines in patients undergoing cardiac surgery for infective endocarditis. Haemoadsorption offers the possibility to stabilise haemodynamics, reduce sepsis-related mortality, and protect organ function. However, until now, there has been no general opinion and consensus regarding the clinical effectiveness of adjunctive intraoperative haemoadsorption in infective endocarditis. Therefore, we reviewed the current literature evaluating haemoadsorption in infective endocarditis patients undergoing cardiac surgery. The review was registered at PROSPERO (CRD42023457632). The online version contains supplementary material available at 10.1007/s12055-024-01701-0.
Identifiants
pubmed: 38827548
doi: 10.1007/s12055-024-01701-0
pii: 1701
pmc: PMC11139808
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
69-77Informations de copyright
© The Author(s) 2024.
Déclaration de conflit d'intérêts
Conflict of interestMT, CB, and GL received speaker honoraria and travel fees from CytoSorbents Europe GmbH; DW is a full-time employee of CytoSorbents Europe GmbH.